DBD earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E 29.13. Updated 2026-07-23.
Diebold Nixdorf (DBD) Research Hub
Diebold Nixdorf (DBD) trades on NYSE, US in the Technology (Software - Application) sector. As of 2026-09-11, shares last closed at 65.62 USD (-1.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 29.13, market cap 3.00B. This hub links to the full technical, earnings and options research available for DBD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Technology (Software - Application) |
|---|---|
| Exchange | NYSE, US |
| Last close | 65.62 USD (-1.29%) |
| 52-week range | 65.04 USD – 91.2 USD |
| Trend regime | Range |
| 14-day RSI | 27.5 (Oversold) |
| Trailing P/E | 29.13 |
| Market cap | 3.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for DBD
Covered Call on DBD: how it works, illustrative setup around the real 65.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DBD: how it works, illustrative setup around the real 65.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DBD: how it works, illustrative setup around the real 65.62 USD price, max profit/loss, breakeven and when to use it. Educational.
DBD technical analysis: range, last 65.62 USD, RSI 27.5, 52w range 65.04 USD–91.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DBD in?
Diebold Nixdorf (DBD) is classified under Technology (Software - Application), listed on NYSE, US.
Is DBD in an uptrend or downtrend?
As of 2026-09-11, DBD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DBD's trailing P/E ratio?
DBD's trailing P/E is 29.13, with a market cap of 3.00B. See the earnings research page for full valuation detail.
When does DBD next report earnings?
DBD is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 1.1 USD.